Alnylam Pharmaceuticals, Inc.
GLYCOCONJUGATES OF RNA INTERFERENCE AGENTS

Abstract:

The present invention relates to agents, compositions and methods for inhibiting the expression of a target gene, comprising an RNAi agent bearing at least one galactosyl moiety. These are useful for delivering the gene expression inhibiting activity to cells, particularly hepatocytes, and more particularly in therapeutic applications.